BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 23978954)

  • 21. The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study.
    Bernstein CN; Wajda A; Blanchard JF
    Clin Gastroenterol Hepatol; 2008 Jan; 6(1):41-5. PubMed ID: 18063423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer Risk in 2621 Chinese Patients with Inflammatory Bowel Disease: A Population-based Cohort Study.
    So J; Tang W; Leung WK; Li M; Lo FH; Wong MTL; Sze ASF; Leung CM; Tsang SWC; Shan EHS; Chan KH; Lam BCY; Hui AJ; Chow WH; Lam TY; Lam V; Lee TW; Lo HHH; Tang CM; Wong CL; Wu JCY; Chan FKL; Sung JJY; Harbord M; Ng SC
    Inflamm Bowel Dis; 2017 Nov; 23(11):2061-2068. PubMed ID: 28991855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammatory bowel diseases, 5-aminosalicylic acid and sulfasalazine treatment and risk of acute pancreatitis: a population-based case-control study.
    Munk EM; Pedersen L; Floyd A; Nørgård B; Rasmussen HH; Sørensen HT
    Am J Gastroenterol; 2004 May; 99(5):884-8. PubMed ID: 15128355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mortality and cancer in pediatric-onset inflammatory bowel disease: a population-based study.
    Peneau A; Savoye G; Turck D; Dauchet L; Fumery M; Salleron J; Lerebours E; Ligier K; Vasseur F; Dupas JL; Mouterde O; Spyckerelle C; Djeddi D; Peyrin-Biroulet L; Colombel JF; Gower-Rousseau C
    Am J Gastroenterol; 2013 Oct; 108(10):1647-53. PubMed ID: 23939626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis.
    Kotlyar DS; Lewis JD; Beaugerie L; Tierney A; Brensinger CM; Gisbert JP; Loftus EV; Peyrin-Biroulet L; Blonski WC; Van Domselaar M; Chaparro M; Sandilya S; Bewtra M; Beigel F; Biancone L; Lichtenstein GR
    Clin Gastroenterol Hepatol; 2015 May; 13(5):847-58.e4; quiz e48-50. PubMed ID: 24879926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in cancer incidence patterns among a northeastern American Indian population: 1955-1969 versus 1990-2004.
    Mahoney MC; Va P; Stevens A; Kahn AR; Michalek AM
    J Rural Health; 2009; 25(4):378-83. PubMed ID: 19780918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory bowel disease, cancer and medication: Cancer risk in the Dutch population-based IBDSL cohort.
    van den Heuvel TR; Wintjens DS; Jeuring SF; Wassink MH; Romberg-Camps MJ; Oostenbrug LE; Sanduleanu S; Hameeteman WH; Zeegers MP; Masclee AA; Jonkers DM; Pierik MJ
    Int J Cancer; 2016 Sep; 139(6):1270-80. PubMed ID: 27170593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of thiopurine and anti-TNF therapy in lymphoma in inflammatory bowel disease.
    Herrinton LJ; Liu L; Weng X; Lewis JD; Hutfless S; Allison JE
    Am J Gastroenterol; 2011 Dec; 106(12):2146-53. PubMed ID: 22031357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of ulcerative colitis and Crohn's disease among offspring of patients with chronic inflammatory bowel disease.
    Orholm M; Fonager K; Sørensen HT
    Am J Gastroenterol; 1999 Nov; 94(11):3236-8. PubMed ID: 10566721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-calculus suppurative cholangitis in Danish patients with inflammatory bowel disease.
    Rasmussen HH; Nørgård B; Olsen ML; Fonager K; Sørensen HT
    Hepatogastroenterology; 2005; 52(61):115-8. PubMed ID: 15783009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of cancer among patients with atopic dermatitis.
    Hagströmer L; Ye W; Nyrén O; Emtestam L
    Arch Dermatol; 2005 Sep; 141(9):1123-7. PubMed ID: 16172309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study.
    Rungoe C; Basit S; Ranthe MF; Wohlfahrt J; Langholz E; Jess T
    Gut; 2013 May; 62(5):689-94. PubMed ID: 22961677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study.
    Katsanos KH; Vermeire S; Christodoulou DK; Riis L; Wolters F; Odes S; Freitas J; Hoie O; Beltrami M; Fornaciari G; Clofent J; Bodini P; Vatn M; Nunes PB; Moum B; Munkholm P; Limonard C; Stockbrugger R; Rutgeerts P; Tsianos EV;
    Digestion; 2007; 75(2-3):113-21. PubMed ID: 17598963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study.
    Askling J; Dickman PW; Karlén P; Broström O; Lapidus A; Löfberg R; Ekbom A
    Lancet; 2001 Jan; 357(9252):262-6. PubMed ID: 11214128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implantable cardioverter-defibrillators and subsequent cancer risk: a nationwide population-based cohort study.
    Pedersen SB; Nielsen JC; Bøtker HE; Farkas DK; Schmidt M; Sørensen HT
    Europace; 2015 Jun; 17(6):902-8. PubMed ID: 25840286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occupation and cancer - follow-up of 15 million people in five Nordic countries.
    Pukkala E; Martinsen JI; Lynge E; Gunnarsdottir HK; Sparén P; Tryggvadottir L; Weiderpass E; Kjaerheim K
    Acta Oncol; 2009; 48(5):646-790. PubMed ID: 19925375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease.
    Romberg-Camps MJ; Dagnelie PC; Kester AD; Hesselink-van de Kruijs MA; Cilissen M; Engels LG; Van Deursen C; Hameeteman WH; Wolters FL; Russel MG; Stockbrügger RW
    Am J Gastroenterol; 2009 Feb; 104(2):371-83. PubMed ID: 19174787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Skin cancer risk among solid organ recipients: a nationwide cohort study in Denmark.
    Jensen AO; Svaerke C; Farkas D; Pedersen L; Kragballe K; Sørensen HT
    Acta Derm Venereol; 2010 Sep; 90(5):474-9. PubMed ID: 20814621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.